NOVARTIS AG-SPONSORED ADR (NVS) Fundamental Analysis & Valuation
NYSE:NVS • US66987V1098
Current stock price
154.24 USD
+0.8 (+0.52%)
Last:
This NVS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. NVS Profitability Analysis
1.1 Basic Checks
- In the past year NVS was profitable.
- In the past year NVS had a positive cash flow from operations.
- Each year in the past 5 years NVS has been profitable.
- In the past 5 years NVS always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of NVS (12.60%) is better than 93.75% of its industry peers.
- The Return On Equity of NVS (30.31%) is better than 94.27% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 19.32%, NVS belongs to the top of the industry, outperforming 95.83% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for NVS is above the industry average of 13.57%.
- The last Return On Invested Capital (19.32%) for NVS is above the 3 year average (17.15%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.6% | ||
| ROE | 30.31% | ||
| ROIC | 19.32% |
ROA(3y)13.05%
ROA(5y)12.66%
ROE(3y)29.75%
ROE(5y)27.29%
ROIC(3y)17.15%
ROIC(5y)14%
1.3 Margins
- NVS has a Profit Margin of 24.83%. This is amongst the best in the industry. NVS outperforms 93.23% of its industry peers.
- In the last couple of years the Profit Margin of NVS has grown nicely.
- NVS has a Operating Margin of 33.18%. This is amongst the best in the industry. NVS outperforms 95.31% of its industry peers.
- NVS's Operating Margin has improved in the last couple of years.
- NVS has a better Gross Margin (75.82%) than 83.33% of its industry peers.
- NVS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.18% | ||
| PM (TTM) | 24.83% | ||
| GM | 75.82% |
OM growth 3Y12.14%
OM growth 5Y6.09%
PM growth 3Y15.69%
PM growth 5Y8.94%
GM growth 3Y0.74%
GM growth 5Y1.28%
2. NVS Health Analysis
2.1 Basic Checks
- NVS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for NVS has been reduced compared to 1 year ago.
- The number of shares outstanding for NVS has been reduced compared to 5 years ago.
- NVS has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 4.40 indicates that NVS is not in any danger for bankruptcy at the moment.
- NVS has a Altman-Z score of 4.40. This is in the better half of the industry: NVS outperforms 73.96% of its industry peers.
- The Debt to FCF ratio of NVS is 2.32, which is a good value as it means it would take NVS, 2.32 years of fcf income to pay off all of its debts.
- NVS's Debt to FCF ratio of 2.32 is amongst the best of the industry. NVS outperforms 94.27% of its industry peers.
- NVS has a Debt/Equity ratio of 0.64. This is a neutral value indicating NVS is somewhat dependend on debt financing.
- The Debt to Equity ratio of NVS (0.64) is worse than 66.15% of its industry peers.
- Even though the debt/equity ratio score it not favorable for NVS, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 2.32 | ||
| Altman-Z | 4.4 |
ROIC/WACC3.65
WACC5.29%
2.3 Liquidity
- A Current Ratio of 1.12 indicates that NVS should not have too much problems paying its short term obligations.
- The Current ratio of NVS (1.12) is worse than 80.73% of its industry peers.
- A Quick Ratio of 0.89 indicates that NVS may have some problems paying its short term obligations.
- The Quick ratio of NVS (0.89) is worse than 78.65% of its industry peers.
- The current and quick ratio evaluation for NVS is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.89 |
3. NVS Growth Analysis
3.1 Past
- NVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.98%, which is quite good.
- The Earnings Per Share has been growing by 9.21% on average over the past years. This is quite good.
- Looking at the last year, NVS shows a quite strong growth in Revenue. The Revenue has grown by 8.91% in the last year.
- NVS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.45% yearly.
EPS 1Y (TTM)14.98%
EPS 3Y13.63%
EPS 5Y9.21%
EPS Q2Q%2.53%
Revenue 1Y (TTM)8.91%
Revenue growth 3Y9.1%
Revenue growth 5Y2.45%
Sales Q2Q%1.39%
3.2 Future
- The Earnings Per Share is expected to grow by 7.48% on average over the next years.
- The Revenue is expected to grow by 4.99% on average over the next years.
EPS Next Y0.69%
EPS Next 2Y4.79%
EPS Next 3Y5.96%
EPS Next 5Y7.48%
Revenue Next Year2.75%
Revenue Next 2Y3.82%
Revenue Next 3Y4.46%
Revenue Next 5Y4.99%
3.3 Evolution
- The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. NVS Valuation Analysis
4.1 Price/Earnings Ratio
- NVS is valuated rather expensively with a Price/Earnings ratio of 17.08.
- Based on the Price/Earnings ratio, NVS is valued cheaper than 84.90% of the companies in the same industry.
- NVS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.71.
- A Price/Forward Earnings ratio of 16.97 indicates a correct valuation of NVS.
- Based on the Price/Forward Earnings ratio, NVS is valued cheaper than 82.29% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of NVS to the average of the S&P500 Index (23.83), we can say NVS is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.08 | ||
| Fwd PE | 16.97 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, NVS is valued cheaply inside the industry as 83.85% of the companies are valued more expensively.
- 84.90% of the companies in the same industry are more expensive than NVS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.41 | ||
| EV/EBITDA | 13.24 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NVS does not grow enough to justify the current Price/Earnings ratio.
- NVS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)24.58
PEG (5Y)1.85
EPS Next 2Y4.79%
EPS Next 3Y5.96%
5. NVS Dividend Analysis
5.1 Amount
- NVS has a Yearly Dividend Yield of 3.06%.
- NVS's Dividend Yield is rather good when compared to the industry average which is at 0.77. NVS pays more dividend than 94.27% of the companies in the same industry.
- NVS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.06% |
5.2 History
- The dividend of NVS has a limited annual growth rate of 5.38%.
- NVS has paid a dividend for at least 10 years, which is a reliable track record.
- NVS has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)5.38%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
- 55.91% of the earnings are spent on dividend by NVS. This is a bit on the high side, but may be sustainable.
- The dividend of NVS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP55.91%
EPS Next 2Y4.79%
EPS Next 3Y5.96%
NVS Fundamentals: All Metrics, Ratios and Statistics
NYSE:NVS (3/16/2026, 12:00:02 PM)
154.24
+0.8 (+0.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)04-27 2026-04-27
Inst Owners41.7%
Inst Owner Change0.15%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap295.95B
Revenue(TTM)56.33B
Net Income(TTM)13.98B
Analysts70.59
Price Target156 (1.14%)
Short Float %0.4%
Short Ratio2.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.06% |
Yearly Dividend4.02
Dividend Growth(5Y)5.38%
DP55.91%
Div Incr Years5
Div Non Decr Years5
Ex-Date03-11 2026-03-11 (4.772961)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.14%
Min EPS beat(2)-2.1%
Max EPS beat(2)-0.17%
EPS beat(4)2
Avg EPS beat(4)1.23%
Min EPS beat(4)-2.1%
Max EPS beat(4)6.59%
EPS beat(8)6
Avg EPS beat(8)2.93%
EPS beat(12)9
Avg EPS beat(12)2.91%
EPS beat(16)11
Avg EPS beat(16)2.66%
Revenue beat(2)0
Avg Revenue beat(2)-3.85%
Min Revenue beat(2)-4.89%
Max Revenue beat(2)-2.82%
Revenue beat(4)0
Avg Revenue beat(4)-2.92%
Min Revenue beat(4)-4.89%
Max Revenue beat(4)-1.13%
Revenue beat(8)2
Avg Revenue beat(8)-1.5%
Revenue beat(12)3
Avg Revenue beat(12)-2.67%
Revenue beat(16)4
Avg Revenue beat(16)-0.2%
PT rev (1m)4.11%
PT rev (3m)15.52%
EPS NQ rev (1m)-1.72%
EPS NQ rev (3m)-8.29%
EPS NY rev (1m)-3.05%
EPS NY rev (3m)-4.01%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-3.1%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.08 | ||
| Fwd PE | 16.97 | ||
| P/S | 5.25 | ||
| P/FCF | 19.41 | ||
| P/OCF | 15.46 | ||
| P/B | 6.42 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.24 |
EPS(TTM)9.03
EY5.85%
EPS(NY)9.09
Fwd EY5.89%
FCF(TTM)7.94
FCFY5.15%
OCF(TTM)9.98
OCFY6.47%
SpS29.36
BVpS24.04
TBVpS-4.61
PEG (NY)24.58
PEG (5Y)1.85
Graham Number69.89
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.6% | ||
| ROE | 30.31% | ||
| ROCE | 22.34% | ||
| ROIC | 19.32% | ||
| ROICexc | 22.42% | ||
| ROICexgc | 94.51% | ||
| OM | 33.18% | ||
| PM (TTM) | 24.83% | ||
| GM | 75.82% | ||
| FCFM | 27.06% |
ROA(3y)13.05%
ROA(5y)12.66%
ROE(3y)29.75%
ROE(5y)27.29%
ROIC(3y)17.15%
ROIC(5y)14%
ROICexc(3y)20.47%
ROICexc(5y)17.14%
ROICexgc(3y)94.66%
ROICexgc(5y)84.88%
ROCE(3y)20.57%
ROCE(5y)16.8%
ROICexgc growth 3Y10.97%
ROICexgc growth 5Y16.26%
ROICexc growth 3Y23.26%
ROICexc growth 5Y13.82%
OM growth 3Y12.14%
OM growth 5Y6.09%
PM growth 3Y15.69%
PM growth 5Y8.94%
GM growth 3Y0.74%
GM growth 5Y1.28%
F-Score8
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 2.32 | ||
| Debt/EBITDA | 1.23 | ||
| Cap/Depr | 73.24% | ||
| Cap/Sales | 6.92% | ||
| Interest Coverage | 19.05 | ||
| Cash Conversion | 79.71% | ||
| Profit Quality | 109.01% | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 4.4 |
F-Score8
WACC5.29%
ROIC/WACC3.65
Cap/Depr(3y)63.14%
Cap/Depr(5y)55.05%
Cap/Sales(3y)6.73%
Cap/Sales(5y)6.62%
Profit Quality(3y)101.15%
Profit Quality(5y)104.02%
High Growth Momentum
Growth
EPS 1Y (TTM)14.98%
EPS 3Y13.63%
EPS 5Y9.21%
EPS Q2Q%2.53%
EPS Next Y0.69%
EPS Next 2Y4.79%
EPS Next 3Y5.96%
EPS Next 5Y7.48%
Revenue 1Y (TTM)8.91%
Revenue growth 3Y9.1%
Revenue growth 5Y2.45%
Sales Q2Q%1.39%
Revenue Next Year2.75%
Revenue Next 2Y3.82%
Revenue Next 3Y4.46%
Revenue Next 5Y4.99%
EBIT growth 1Y14.46%
EBIT growth 3Y22.35%
EBIT growth 5Y8.7%
EBIT Next Year11.91%
EBIT Next 3Y9.08%
EBIT Next 5Y8.66%
FCF growth 1Y10.42%
FCF growth 3Y9.64%
FCF growth 5Y6.62%
OCF growth 1Y8.66%
OCF growth 3Y10.38%
OCF growth 5Y7%
NOVARTIS AG-SPONSORED ADR / NVS Fundamental Analysis FAQ
What is the ChartMill fundamental rating of NOVARTIS AG-SPONSORED ADR (NVS) stock?
ChartMill assigns a fundamental rating of 7 / 10 to NVS.
What is the valuation status for NVS stock?
ChartMill assigns a valuation rating of 6 / 10 to NOVARTIS AG-SPONSORED ADR (NVS). This can be considered as Fairly Valued.
How profitable is NOVARTIS AG-SPONSORED ADR (NVS) stock?
NOVARTIS AG-SPONSORED ADR (NVS) has a profitability rating of 9 / 10.
How financially healthy is NOVARTIS AG-SPONSORED ADR?
The financial health rating of NOVARTIS AG-SPONSORED ADR (NVS) is 7 / 10.
Is the dividend of NOVARTIS AG-SPONSORED ADR sustainable?
The dividend rating of NOVARTIS AG-SPONSORED ADR (NVS) is 7 / 10 and the dividend payout ratio is 55.91%.